Vimarsana
Biggest News Aggregation in the World

Tim Arens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Arens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Arens Today - Breaking & Trending Today

Regional business leaders share their perspectives - Vimarsana News

Regional business leaders share their perspectives

Published: March 11, 2024

This month we asked: What’s the best business advice you’ve received and why?

Source: grandforksherald.com
Related Topics:
Julie WhitneyTroy WalkerTim Arens Ackerman EstvoldTim ArensBremer BankDakota Carrier NetworkPrairie Business MagazineVice PresidentCommercial BankingSenior Civil Transportation
Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript - Vimarsana News

Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript

Published: November 11, 2023

Operator: Welcome everyone to Surmodics Fourth Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.

Source: insidermonkey.com
Related Topics:
New YorkUnited StatesTim ArensGary MaharajPerformance Coating ServicesSurmodics IncCall Transcript NovemberSurmodics Fourth QuarterFiscal YearInvestor RelationsPrivate Securities Litigation Reform ActSurmodic PresidentChief ExecutiveMedical DevicePerformance CoatingsPounce Arterial ThrombectomyVitro DiagnosticsSublime RadialMedical Device Performance CoatingsPounce Venous Thrombectomy SystemPounce SublimeChief Financial OfficerPerformance CoatingSerene CoatingVeil Drug Coated Balloon
Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript - Vimarsana News

Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript

Published: May 3, 2023

Operator: Welcome everyone to Surmodics’ Second Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.

Source: insidermonkey.com
Related Topics:
Mike MatsonGary MaharajTim ArensTimothy ArensSurmodics IncPeripheral Intervention CommunityCall Transcript AprilSurmodic Second QuarterFiscal YearInvestor RelationsSafe Harbor ProvisionsPrivate Securities Litigation Reform ActSurmodics PresidentChief ExecutiveSurveil Drug Coated BalloonSublime RadialPounce Arterial ThrombectomyMedical Device CoatingsEndovascular TodayPounce ArterialPounce Venous ThrombectomySublime Radial AccessLow ProfilePounce ExcelChief Financial Officer
Surmodics, Inc. (NASDAQ:SRDX) Q1 2023 Earnings Call Transcript - Vimarsana News

Surmodics, Inc. (NASDAQ:SRDX) Q1 2023 Earnings Call Transcript

Published: February 9, 2023

Operator: Welcome everyone to Surmodics' First Quarter of Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.

Source: insidermonkey.com
Related Topics:
Ramon VarcoeMike MatsonMichael MatsonJames SidotiMike PetuskyGary MaharajTim ArensSurmodics IncNeedham CompanyValue Analysis CommitteeSidoti CompanyBarrington ResearchInternational Symposium On Endovascular TherapyCompany RepresentativesCall Transcript FebruaryChief Executive Officer Tim ArensChief FinancialSurmodic First QuarterFiscal YearInvestor RelationsSafe Harbor ProvisionsPrivate Securities Litigation Reform ActSurmodics PresidentChief ExecutiveMedical Device
Surmodics, Inc.: 6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe - Vimarsana News

Surmodics, Inc.: 6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe

Published: October 11, 2022

Sundance Sirolimus DCB demonstrates lowest binary restenosis at 6 months compared to relevant BTK clinical trials Excellent safety profile observed with no major amputations and low rates of MAE Surmodics

Source: finanznachrichten.de
Related Topics:
United StatesEden PrairieNew ZealandRamon VarcoeAndrew HoldenSundance SirolimusTim ArensSurmodics IncAmputation Prevention SymposiumLate Lumen LossProfessor Ramon VarcoeSwing TrialProfessor Andrew HoldenSundance Sirolimus Drug CoatedSundance Sirolimus Drug Coated BalloonAnnual Report